Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Legendre

Showing results (21-30 of 456) with videos related to

Pageof 46
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 29, 2008
Improving outcomes for solid-organ transplant recipients at risk from cytomegalovirus infection: late-onset disease and indirect consequencesChristophe Legendre, Manuel Pascual
Transplantation|June 4, 2014
At the end of the day, should we consider chronic histological lesions?Dany Anglicheau, Christophe Legendre
Transplantation|November 19, 2020
Solid Organ Transplantation in the Era of COVID-19: Lessons from FranceMohamad Zaidan, Christophe Legendre
International Journal of Computational Biology and Drug Design|January 12, 2010
BIPASS: design of alternative splicing servicesZoé Lacroix, Christophe Legendre
Pharmacogenomics|November 5, 2010
Deciphering calcineurin inhibitor nephrotoxicity: a pharmacological approachNicolas Pallet, Christophe Legendre
Clinics and Research in Hepatology and Gastroenterology|August 13, 2013
Viral hepatitis and the kidneyStanislas Pol, Christophe Legendre
The Journal of Infectious Diseases|September 28, 2002
The economic value of valacyclovir prophylaxis in transplantationJean-Paul Squifflet, Christophe Legendre
Transplant International : Official Journal of the European Society for Organ Transplantation|October 22, 2013
Factors influencing long-term outcome after kidney transplantationChristophe Legendre, Guillaume Canaud, Frank Martinez
Transplantation Reviews (Orlando, Fla.)|July 29, 2008
Kaposi sarcoma in transplantationCéleste Lebbé, Christophe Legendre, Camille Francès
Transplantation|June 13, 2018
FSGS ACTH Gel: Part of the Answer?Marianne Delville, Guillaume Canaud, Christophe Legendre
Pageof 46

Showing results (21-30 of 456) with videos related to

Sort By:
Pageof 46
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 29, 2008
Improving outcomes for solid-organ transplant recipients at risk from cytomegalovirus infection: late-onset disease and indirect consequencesChristophe Legendre, Manuel Pascual
Transplantation|June 4, 2014
At the end of the day, should we consider chronic histological lesions?Dany Anglicheau, Christophe Legendre
Transplantation|November 19, 2020
Solid Organ Transplantation in the Era of COVID-19: Lessons from FranceMohamad Zaidan, Christophe Legendre
International Journal of Computational Biology and Drug Design|January 12, 2010
BIPASS: design of alternative splicing servicesZoé Lacroix, Christophe Legendre
Pharmacogenomics|November 5, 2010
Deciphering calcineurin inhibitor nephrotoxicity: a pharmacological approachNicolas Pallet, Christophe Legendre
Clinics and Research in Hepatology and Gastroenterology|August 13, 2013
Viral hepatitis and the kidneyStanislas Pol, Christophe Legendre
The Journal of Infectious Diseases|September 28, 2002
The economic value of valacyclovir prophylaxis in transplantationJean-Paul Squifflet, Christophe Legendre
Transplant International : Official Journal of the European Society for Organ Transplantation|October 22, 2013
Factors influencing long-term outcome after kidney transplantationChristophe Legendre, Guillaume Canaud, Frank Martinez
Transplantation Reviews (Orlando, Fla.)|July 29, 2008
Kaposi sarcoma in transplantationCéleste Lebbé, Christophe Legendre, Camille Francès
Transplantation|June 13, 2018
FSGS ACTH Gel: Part of the Answer?Marianne Delville, Guillaume Canaud, Christophe Legendre
Pageof 46